Research programme: Non narcotic analgesics - Vapogenix

Drug Profile

Research programme: Non narcotic analgesics - Vapogenix

Latest Information Update: 16 Feb 2017

Price : $50

At a glance

  • Originator University of Texas M. D. Anderson Cancer Center; Vapogenix
  • Class Anaesthetics; Analgesics; Anti-inflammatories; Non-opioid analgesics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Pain
  • Research Inflammatory pain

Most Recent Events

  • 16 Feb 2017 Early research in Inflammatory pain in USA (Topical) (Texas Emerging Technology pipeline, January 2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top